![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
TOXICAN: a guide for grading dermatological adverse events of cancer treatments
The dermatological toxicity of cancer treatments is frequent and sometimes debilitating. Its reference classification, the NCI-CTCAE (National Cancer Institute–Common Terminology Criteria for Adverse Events), ...
-
Article
Changes in quality of life after a diagnosis of cancer: a 2-year study comparing breast cancer and melanoma patients
Longitudinal studies addressing change in health-related quality of life (HRQoL) following a diagnosis of cancer have mainly focused on a single cancer type, and little is known about the differences in HRQoL...
-
Article
Incidence and characteristics of melanoma brain metastases develo** during treatment with vemurafenib
Vemurafenib is indicated for the treatment of patients with BRAF V600 -mutant metastatic melanoma. We studied for the first time the characteristics of brain met...
-
Article
Spiritualité et changement de valeurs chez des patients atteints d’un mélanome: une étude qualitative exploratoire
Au coeur de débats théoriques et méthodologiques, la spiritualité est un concept psychologique qui suscite depuis quelques années un intérêt grandissant en santé. Dans le but de conduire un travail de recherch...